Cardiovascular risk factors in patients with type 2 diabetes -: Do we follow the guidelines?

被引:30
|
作者
del Cañizo-Gómez, FJ
Moreira-Andrés, MN
机构
[1] Hosp Virgen Torre, Endocrinol Unit, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Endocrinol, Madrid 28041, Spain
关键词
type 2 diabetes mellitus; cardiovascular risk factors; coronary artery disease; hypertension; dyslipidaemia;
D O I
10.1016/j.diabres.2003.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the degree of control of modifiable cardiovascular risk factors (CRFs) in type 2 diabetic patients. Study design and methods: Cross-sectional study in 501 patients with type 2 diabetes mellitus. The following parameters were used to define optimal control: glycated haemoglobin (HbA(1c)) <7.0%, fasting plasma glucose (FPG) <7.2 mmol/l, postprandial capillary glucose (PCG) <10.0mmol/l, high-density lipoprotein cholesterol (HDL-C) >1,1 mmol/l, low-density lipoprotein cholesterol (LDL-C) <2.6 mmol/l, triglyceride levels (TG) < 1.7 mmol/l, systolic blood pressure (SBP) < 130 mmHg, diastolic blood pressure (DBP) <80 mmHg, body mass index (BMI) <25kg/m(2), waist circumference (WC) <88cm in women and < 102 cm in men, and current non-smoking status. The use of various cardioprotective medications was also evaluated. Results: Mean ( +/-S.D.) age was 65.4 +/- 11.9 years, 218 (44%) were male. Ninety-six (19%) met coronary artery disease (CAD). Two hundred seven patients (41%) had an HbA(1c) <7.0%, 134 (27%) a FPG <7.2 mmol/l and 231 of 353 (65%) a PCG < 10.0 mmol/l. Only 206 (41%) achieved an LDL-C <2.6 mmol/l, but 370 (74%) and 308 (62%) reached an HDL-C > 1.1 mmol/l and a TG levels < 1.7 mmol/l, respectively. In 359 (72%) patients DBP was < 80 mmHg, but in only 136 (27%) was SBP < 130 mm-Hg. Sixty four (13%) achieved a BMI <25 kg/m(2), and 420 (84%) were non-smokers. Forty three (15%) women and 104 (48%) men had a WC <88 or <102 cm, respectively. None of the patients had optimal control of all CRFs. Conclusions: These data demonstrate poor control of modifiable CRFs in the population studied, and support the need for great effort to achieve the recommended goals. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 50 条
  • [1] HOW DO WE FOLLOW THE GUIDELINES IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES?
    Toprak, Ilkim Deniz
    Alibakan, Ozlem Kandemir
    Kostek, Betul
    Acar, Mehmet Alptekin
    Aslan, Ipek Bilge
    Yilmaz, Ugur
    Eruzun, Hasan
    Arman, Yucel
    Tukek, Tufan
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2021, 84 (03): : 369 - 375
  • [2] Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?
    George, PB
    Tobin, KJ
    Corpus, RA
    Devlin, WH
    O'Neill, WW
    AMERICAN HEART JOURNAL, 2001, 142 (05) : 857 - 863
  • [3] Attenuating cardiovascular risk factors in patients with type 2 diabetes
    Garber, AJ
    AMERICAN FAMILY PHYSICIAN, 2000, 62 (12) : 2633 - 2642
  • [4] Targeting cardiovascular risk factors in patients with type 2 diabetes
    Holt, R
    DIABETES OBESITY & METABOLISM, 2003, 5 (04): : 269 - 269
  • [5] Cardiovascular risk factors in patients with type 2 diabetes mellitus
    Carolina Vintimilla, Evelin
    Vintimilla Molina, Jhojana Rosati
    Carmendel Rocio Parra
    Martinez Santander, Diana Antonieta
    Martinez Santander, Carlos Jose
    del Rocio Andrade, Neida
    Cumbe Guerrero, Karla Maria
    Cardenas Heredia, Fredy Rosendo
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (04): : 356 - 360
  • [6] Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes
    Goldberg, RB
    AMERICAN JOURNAL OF MANAGED CARE, 2000, 6 (13): : S682 - S691
  • [7] Cardiovascular risk factors in Turkish immigrants with type 2 diabetes mellitus: do they resemble the Dutch patients?
    Uitewaal, P
    Bruijnzeels, M
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2002, 12 (04): : 103 - 103
  • [8] Reducing the cardiovascular risk at patients with type 2 diabetes by controlling the risk factors
    Tudor, C.
    Jeberean, R. A.
    Buzas, R.
    Popescu, A.
    Ionita, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 346 - 346
  • [9] Cardiovascular Risk, Risk Knowledge, and Related Factors in Patients With Type 2 Diabetes
    Zehirlioglu, Lemye
    Mert, Hatice
    Sezgin, Dilek
    Ozpelit, Ebru
    CLINICAL NURSING RESEARCH, 2020, 29 (05) : 322 - 330
  • [10] Excess cardiovascular risk in patients with type 2 diabetes: do we need to look beyond LDL cholesterol?
    Rees, Alan
    BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE, 2014, 14 (01): : 10 - 20